SKI Market

A+| A| A-|

Indian Indices

Sensex

77,328.19 -516.33
( -0.66%)

Global Indices

Nasdaq

49,628.48 -303.12
(-0.61%)

Dow Jones

7,359.75 -26.37
(-0.36%)

Hang Seng

62,681.30 -152.54
(-0.24%)

Nikkei 225

10,228.01 -48.94
(-0.48%)

Forex

USD-INR

94.67 -0.51
(-0.53%)

EUR-INR

111.19 -0.10
(-0.09%)

GBP-INR

128.70 -0.19
(-0.14%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Coral Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524506

INE683E01017

596.8851541

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

10.95

156.47

EPS(TTM)

Face Value()

Div & Yield %

40.01

Back

bosch ltd

Nilkamal consolidated net profit rises 3.20% in the September 2025 quarter

Nov 06,2025

Net profit of Nilkamal rose 3.20% to Rs 33.57 crore in the quarter ended September 2025 as against Rs 32.53 crore during the previous quarter ended September 2024. Sales rose 17.76% to Rs 967.71 crore in the quarter ended September 2025 as against Rs 821.76 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	967.71	821.76	18
OPM %	8.81	9.42	-
PBDT	79.83	72.51	10
PBT	45.06	42.83	5
NP	33.57	32.53	3

77,328.19 -516.33 ( -0.66%)

49,628.48 -303.12 (-0.61%)

7,359.75 -26.37 (-0.36%)

62,681.30 -152.54 (-0.24%)

10,228.01 -48.94 (-0.48%)

94.67 -0.51 (-0.53%)

111.19 -0.10 (-0.09%)

128.70 -0.19 (-0.14%)

0.60 0.00 (0.12%)